Bank of New York Mellon’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History
Bought
Maintained
Sold
Other funds holding TMBR
TRCT
CPG
SPIA
Bank of New York Mellon's TMBR Position: Q2 2023 in Review
Bank of New York Mellon sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2023, closing a stake of 13,401 shares — an estimated $22.8K sold.
Bank of New York Mellon first reported a position in TMBR in Q1 2017 and held it in 7 quarters. The position peaked at $49K in Q1 2021. 9 funds tracked by Wall St. Rank hold TMBR as of Q2 2023.
- Bank of New York Mellon reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
- Bank of New York Mellon sold 13,401 Timber Pharmaceuticals, Inc. shares in Q2 2023, an estimated $22.8K.
- Bank of New York Mellon first reported a position in Timber Pharmaceuticals, Inc. in Q1 2017 and held it in 7 quarters.
- Bank of New York Mellon's Timber Pharmaceuticals, Inc. position peaked at $49K in Q1 2021.
- 9 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2023.
Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.